IP Library › Granted Patent US 9,273,137
Granted Patent B2
US 9,273,137 · App. 13/842,345 · Granted Mar 1, 2016

FGFR-Fc fusion proteins and the use thereof

Inventors: Jianmin Fang (Yantai, CN); Dong Li (Yantai, CN)
Assignee: REMEGEN, LTD.
C07K16/2863A61K47/48369A61K47/48423C07K14/71A61K38/00C07K2319/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,273,137
App. No.
13/842,345
Granted
Mar 1, 2016
Kind
B2
Abstract

The present invention belongs to the field of biotechnology and relates to the treatment of diseases, especially the treatment of FGF overexpression-related diseases. Particularly, the present invention relates to FGFR-Fc fusion proteins and the use thereof in the treatment of angiogenesis regulation-related diseases. More particularly, the present invention relates to isolated soluble FGFR-Fc fusion proteins and their applications in manufacture of the medicament for the treatment of angiogenesis regulation-related diseases.

Claims (6)

1. An isolated soluble fusion protein comprising SEQ ID NO: 12.

2. An isolated soluble fusion protein comprising SEQ ID NO: 13.

3. An isolated soluble fusion protein comprising SEQ ID NO: 14.

4. The isolated soluble fusion protein, according to claim 1 , which consists of SEQ. ID NO:12.

5. The isolated soluble fusion protein, according to claim 2 , which consists of SEQ. ID NO:13.

6. The isolated soluble fusion protein, according to claim 3 , which consists of SEQ. ID NO:14.

Assignments (2)
CHANGE OF NAME Recorded Jan 11, 2016
From: YANTAI RC BIOTECHNOLOGIES, LTD.
To: REMEGEN, LTD.
Reel/Frame 037472/0327 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2015
From: FANG, JIANMIN; LI, DONG
To: YANTAI RC BIOTECHNOLOGIES, LTD.
Reel/Frame 034935/0251 →
Priority Claims (1)
CN 2011 1 01322189 · May 20, 2011 · national
Continuity (2)
Continuation In Part PCTCN2012075706 · May 18, 2012
Related Publication 20130195864A1 · Aug 1, 2013